Skills and experience. Mr Perreault has more than 35 years of experience across both the global biotech and pharmaceutical industries. He was appointed Chief Executive Officer and Managing Director of CSL Limited in July 2013, and was appointed to the CSL Board of Directors the same year.
DA:84PA:64MOZ Rank:100
BioUtah Announces CSL Limited CEO Paul Perreault as ...
BioUtah Announces CSL Limited CEO Paul Perreault as Keynote Speaker at the 2020 Virtual Utah Life Sciences Summit. Other headline speakers include Dr. Jeffrey Shuren, director of the Center for ...
Paul Perreault, CEO and Managing Director, CSL Limited. Paul Perreault. Paul Perreault was appointed Chief Executive Officer (CEO) and Managing Director of CSL Limited in July 2013. Since then, CSL has grown to become the world's third largest biotechnology company with 27,000+ employees providing lifesaving products to 100+ countries.
DA:86PA:95MOZ Rank:66
Paul Perreault - CEO & Managing Director, CSL Ltd. - CSL ...
I’m the CEO and Managing Director of CSL Limited. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our two businesses,...
DA:51PA:66MOZ Rank:34
CSL Limited (CSLLY) CEO Paul Perreault on Q2 2021 Results ...
It's Mark Dehring speaking, and joining me online is Paul Perreault, CSL's Chief Executive Officer; and John Levy, who is our Interim Chief Financial Officer.
DA:14PA:93MOZ Rank:17
CSL CEO Paul Perreault Earns 2018 Most Admired CEOs ...
KING OF PRUSSIA, Pa. – December 6, 2018 – Paul Perreault, CEO and Managing Director of CSL Limited, is one of the Philadelphia Business Journal’s Most Admired CEOs for 2018, recognizing his patient-focused leadership of the world’s fifth largest biotechnology company.
The Global Leadership Group is responsible for the day to day running of CSL. Dr. Brian McNamee Chair Member of Corporate Governance and Nomination Committee and the Securities and Market Disclosure Committee
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
DA:88PA:47MOZ Rank:49
Charlene Pang - CEO - Hong Kong CSL Limited | LinkedIn
CEO at Hong Kong CSL Limited Hong Kong. Join to Connect Hong Kong CSL Limited. Report this profile Experience CEO Hong Kong CSL Limited View Charlene’s full profile See who you know in common Get introduced Contact Charlene directly Join to view full profile People also viewed ...